Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma.
双重 ALK/FAK 抑制剂 ESK440 在 ALK 驱动的神经母细胞瘤中的治疗益处
期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2024.100964
Chugh Seema, Tien Jean C, Hon Jennifer, Kenum Carson, Mannan Rahul, Cheng Yunhui, Li Chi Chiang, Taher Zainab I, Delekta Andrew D, Bawa Pushpinder Singh, Apel Ingrid J, Miner Stephanie J, Cao Xuhong, Mehra Rohit, Dhanasekaran Saravana M, Qiao Yuanyuan, Mody Rajen, Chinnaiyan Arul M